AAA Biotech, a global leader in research reagents, has announced the addition of new recombinant proteins to its product line, aiming to further support life sciences research. The company, which already offers over 600 recombinant antibodies, is expanding its portfolio to meet the diverse needs of scientists studying protein interactions, drug discovery, and biomarker validation.
Recombinant proteins are essential tools in modern life sciences, produced through genetic engineering in systems such as E. coli, mammalian cells (HEK293, CHO), yeast, and insect cells. AAA Biotech ensures strict quality control, with purities exceeding 95% via validated affinity chromatography. The proteins are available in multiple formats, including His, GST, FLAG, and Fc fusion tags, facilitating purification and detection.
The expanded portfolio features high purity and bioactivity, with most proteins guaranteed at least 95% purity and tested for functional activity. Proteins are expressed in various systems to ensure proper folding and post-translational modifications. They are suitable for applications such as protein-protein and protein-DNA interaction studies, functional assays, ELISA standardization, and immune signaling analysis.
AAA Biotech also offers custom expression and tagging options to meet specific experimental requirements. Each product undergoes rigorous quality control, including SDS-PAGE, endotoxin testing, and activity assays, with Certificates of Analysis provided per batch. Proteins are supplied in lyophilized or liquid formats for ease of storage and handling.
For more information, visit the company's official website at https://www.aaabiotech.com/.
